Novo Nordisk A/S (NVO)
58.74
-0.90
(-1.51%)
USD |
NYSE |
Jan 14, 12:19
Novo Nordisk Market Cap: 261.01B for Jan. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ascendis Pharma A/S | 13.38B |
| Evaxion AS | 31.58M |
| Regeneron Pharmaceuticals, Inc. | 79.49B |
| Omeros Corp. | 909.65M |
| Viking Therapeutics, Inc. | 3.745B |
Market Cap Related Metrics
| PE Ratio | 17.11 |
| PS Ratio | 5.604 |
| PEG Ratio | 1.512 |
| Price to Book Value | 12.87 |
| Price to Free Cash Flow | 28.30 |
| Price | 58.74 |
| Earnings Yield | 5.84% |
| PEGY Ratio | 1.204 |
| Operating PE Ratio | 13.21 |
| Normalized PE Ratio | 17.11 |